US Edition
Waitrose boss vows to relocate ‘terribly organised’ shops
Overhaul comes amid battle to turn around the wider John Lewis business
Advertisement
-
Savings deals plunge below 5pc – here are the best surviving rates
Interest rates may have peaked but savers can still beat inflation
-
This week’s best savings rates
Discover the market leaders for Isas, bonds, savings and current accounts
-
‘NatWest refuses to tell me who paid £2k into my current account’
Katie Morley Investigates: our reader is flummoxed by this unexpected windfall
-
Our independence must be guaranteed
The Telegraph’s readers need to be reassured about how the paper’s continued independence can be sustained
-
Ministers ‘should halt Abu Dhabi takeover of The Telegraph’
Strong grounds to stop RedBird IMI deal being completed, say rival bidder’s lawyers
-
Top Gear taken off air ‘for the foreseeable future’ after Flintoff crash, says BBC
Motoring show could be at the end of of the road, with hosts in talks with corporation to develop new projects
-
Queen condemns abuse of female journalists and online disinformation
Royal also hails women as among ‘bravest reporters of all’ during keynote address at the Foreign Press Association Awards
-
The truth behind Black Friday’s discounting bonanza
Don’t be deceived by exaggerated price drops on the ‘cheapest’ day of the year
-
Cafe’s VAT battle proves why it pays to fight back against the taxman
Tax Tips: Don't let the taxman take the (VAT-free) biscuit
-
Self-checkouts to blame for middle-class shoplifting, says M&S chairman
Faulty technology encouraging shoppers to walk out without paying amid rise in thefts
-
Middle-class kitchen staple Le Creuset hit by post-pandemic sales slump
French homeware brand blames cost of living crisis and rising interest rates
Advertisement
-
Ex-Morgan Stanley chairman sues Austrian tycoon’s empire over $14m ‘unpaid fees’
Rene Benko is alleged to have made agreement at a Mayfair private members club in 2015
-
Labour council was warned about unsafe balconies a year before collapse
Homeowners say their repeated complaints about safety defects were ignored
-
Sunak must seize this moment to smash up planning rules
Politicians should remember that building homes is where the growth is
-
The darkest hour usually comes before the dawn and it looks very dark for this stock right now
Questor share tip: the valuation appears to take account of a lot of bad news and not much good
-
There’s a crushing political consensus that Britain’s destiny is to be poor
Petrified of criticism, our politicians run from the idea that the economy can ever be fixed
-
Man crushed to death by robot that mistook him for a box of vegetables
Plant owner calls for 'precise and safe system' after second serious incident involving automated machinery
-
Tata Steel to cut thousands of jobs as part of net zero drive
Three quarters of roles at Tata Steel’s Port Talbot mill face the axe in switch to electric furnaces
-
Aston Martin’s turnaround hit by production delays as losses mount
Output of carmaker’s flagship DB12 model hit by supply chain and software challenges
-
Offshore wind projects to receive subsidies boost after auction flop
Claire Coutinho to announce 70pc increase to guaranteed price offered to developers
-
Energy Secretary poised to approve hydrogen trial despite local protests
Up to 2,000 homes in Redcar could be supplied with gas alternative under scheme
-
Gas-fired power stations help triple profits at energy giant SSE
Company triples earnings from its thermal power division
-
Ørsted asks for more government cash amid doubts over flagship wind farm project
Ørsted battles spiralling costs in Hornsea 3 amid rising inflation
Advertisement
-
Elephants don’t gallop – except for AstraZeneca
Questor share tip: the company’s growth rate and valuation suggest further capital gains are ahead
-
Weight-loss drug maker to spend £4.9bn on new facilities amid surging demand
Novo Nordisk is struggling to meet a surge in demand for its treatments
-
AstraZeneca bets on weight-loss pill to compete with wave of new ‘miracle’ jabs
Pharmaceutical giant strikes deal to develop new drugs after admitting it is behind rivals
-
Shortage of weight-loss drug Wegovy will last for years
Sales of Novo Nordisk's obesity treatments grew 36pc in the first nine months of the year
-
GSK is winning its legal battles, yields 4pc and is far cheaper than rivals
Questor share tip: While it's not out of the legal woods yet, several cases have been dismissed and momentum is building day-to-day
-
After a tenfold gain on a drugs maker, here is that investor’s next choice
Questor share tip: The Swiss pharmaceutical company appears to offer the same potential that Eli Lilly did before its 987pc gain
-
Thames Water falls short of £1bn fundraising target amid nationalisation threat
Shareholders agree to inject funds but water supplier still needs £2.5bn by 2030
-
Water suppliers will be forced to increase household bills, says Ofwat boss
Concerns grow that consumers will face costs of fixing creaking water infrastructure
-
£1bn will not be enough to steady Thames Water, warns industry regulator
Ofwat admits it could have done more to prevent toxic build-up of debt in the industry
-
The water industry doesn’t need to be nationalised, it needs to be better policed
Instinctive calls for a state takeover ignore the fundamental of a complex sector
